Home › Companies › STANDARD BIOTOOLS INC. › 2024-2025

STANDARD BIOTOOLS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and STANDARD BIOTOOLS INC.’s Form 8-K, filed June 20, 2025 (Item 5.07 on EDGAR). Page generated November 1, 2026.

  • 5Ballot items
  • 137Asset managers
  • 741Fund votes
  • June 18, 2025Meeting date

Results at a glance

Meeting of June 18, 2025: 5 items on STANDARD BIOTOOLS INC.’s Form 8-K, filed June 20, 2025: 2 elected · 3 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore STANDARD BIOTOOLS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by STANDARD BIOTOOLS INC.

These tallies are STANDARD BIOTOOLS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 20, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

STANDARD BIOTOOLS INC. — official shareholder meeting results, meeting held June 18, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Kathy Hibbs 235,917,851---- 9,416,47081,530,196 96%Elected—
Elect Director: Frank Witney, Ph.D. 240,269,516---- 5,064,80581,530,196 98%Elected—
2. Advisory Vote on Approval of Executive Compensation 241,143,5344,006,163184,624 --81,530,196 98%Approved—
3. Ratification of Appointment of Independent Registered Public Accounting Firm 322,915,2813,650,720298,516 ---- 99%Approved—
4. Approval of the Amendment to the Amended and Restated 2011 Equity Incentive Plan, as Amended 223,394,56319,589,9732,349,785 --81,530,196 92%Approved—

Source: STANDARD BIOTOOLS INC., Form 8-K, filed with the SEC on June 20, 2025 — read the filing on EDGAR.

How asset managers voted at the STANDARD BIOTOOLS INC. 2024-2025 meeting

Each item below shows how the 137 asset managers that disclosed a STANDARD BIOTOOLS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Frank Witney, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 240,269,516WITHHELD: 5,064,805
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Directors: Frank Witney, Ph.D.

STANDARD BIOTOOLS INC.’s own tally for this item (“Elect Director: Frank Witney, Ph.D.”): 240,269,516 for, 5,064,805 withheld, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to serve as Class III directors, to hold office until the Company's 2028 annual meeting of stockholders or until their respective successors have been duly elected and qualified or their earlier resignation or removal:”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 52,011,800 for, 275,381 withheld.

FOR
FOR: 52,011,800WITHHOLD: 275,381
Largest asset managers voting on “Election of Directors: Frank Witney, Ph.D.” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,914,8130 00For
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce2,240,5030 00For
Neuberger Berman1,088,2720 00For
TIAA748,2940 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust00 0245,823Withhold
Lincoln Financial218,8000 00For
Global X177,9030 00For
AIG/SunAmerica154,5260 00For
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock108,1740 00For
Voya86,4970 00For
ProShares59,0110 00For
SEI49,6000 00For
Victory Capital42,6220 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

2. Elect Director: Kathy Hibbs

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 235,917,851WITHHELD: 9,416,470
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of Directors: Kathy Hibbs

STANDARD BIOTOOLS INC.’s own tally for this item (“Elect Director: Kathy Hibbs”): 235,917,851 for, 9,416,470 withheld, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were elected to serve as Class III directors, to hold office until the Company's 2028 annual meeting of stockholders or until their respective successors have been duly elected and qualified or their earlier resignation or removal:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 50,936,118 for, 1,351,063 withheld.

FOR
FOR: 50,936,118WITHHOLD: 1,351,063
Largest asset managers voting on “Election of Directors: Kathy Hibbs” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,599,1230 0315,690Mixed
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce2,240,5030 00For
Neuberger Berman1,088,2720 00For
TIAA00 0748,294Withhold
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust245,8230 00For
Lincoln Financial00 0218,800Withhold
Global X177,9030 00For
AIG/SunAmerica154,5260 00For
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock108,1740 00For
Voya86,4970 00For
ProShares59,0110 00For
SEI49,6000 00For
Victory Capital42,6220 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

3. 4. Approval of the Amendment to the Amended and Restated 2011 Equity Incentive Plan, as Amended

Official resultCOMPENSATIONReported outcome: Approved

92% Approved · of votes cast

FOR 92%
FOR: 223,394,563AGAINST: 19,589,973
Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN, AS AMENDED, TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 17,400,000 SHARES.

STANDARD BIOTOOLS INC.’s own tally for this item (“4. Approval of the Amendment to the Amended and Restated 2011 Equity Incentive Plan, as Amended”): 223,394,563 for, 19,589,973 against — passed, per its Form 8-K filed June 20, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve the amendment to the Plan to increase the shares of common stock reserved thereunder by 17,400,000 shares was approved by the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 48,662,767 for, 1,384,038 against, 2,240,503 abstained.

FOR
FOR: 48,662,767AGAINST: 1,384,038ABSTAIN: 2,240,503
Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN, AS AMENDED, TO INCREASE THE NU” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,599,123315,690 00Mixed
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce00 2,240,5030Abstain
Neuberger Berman1,088,2720 00For
TIAA748,2940 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust0245,823 00Against
Lincoln Financial0218,800 00Against
Global X177,9030 00For
AIG/SunAmerica0154,526 00Against
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock0108,174 00Against
Voya086,497 00Against
ProShares059,011 00Against
SEI49,6000 00For
Victory Capital042,622 00Against

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

4. 2. Advisory Vote on Approval of Executive Compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 241,143,534AGAINST: 4,006,163
Details: description as filed, official tally, votes by 137 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement.

STANDARD BIOTOOLS INC.’s own tally for this item (“2. Advisory Vote on Approval of Executive Compensation”): 241,143,534 for, 4,006,163 against — passed, per its Form 8-K filed June 20, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2024 was approved by the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 40 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy s” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,599,123315,690 00Mixed
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce2,240,5030 00For
Neuberger Berman1,088,2720 00For
TIAA748,2940 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust245,8230 00For
Lincoln Financial218,8000 00For
Global X177,9030 00For
AIG/SunAmerica154,5260 00For
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock108,1740 00For
Voya86,4970 00For
ProShares59,0110 00For
SEI49,6000 00For
Victory Capital42,6220 00For

Fund voting reports, all 40 managers: 51,941,711 for, 345,470 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 110 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy s” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Casdin Capital, LLC76,075,6360 00For
VIKING GLOBAL INVESTORS LP58,651,1700 00For
Morgan Stanley9,865,4660 00For
BlackRock6,372,7920 00For
Nikko Asset Management Co., Ltd.6,207,4590 00For
GEODE CAPITAL MANAGEMENT, LLC5,374,4380 00For
Neuberger Berman3,738,6770 00For
State Street2,941,703256 00For
MAK CAPITAL ONE LLC2,845,8020 00For
Charles Schwab2,527,6550 00For
Pacific Capital Partners Ltd1,625,0000 00For
Northern Trust1,442,1540 00For
MELLON INVESTMENTS Corp1,023,7390 00For
Nuveen781,1820 00For
Vanguard595,5280 00For
PRIMECAP MANAGEMENT CO/CA/594,5740 00For
AQR579,4200 00For
STRS OHIO428,6300 00For
UBS0333,292 00Against
ROCKEFELLER FINANCIAL LLC332,0850 00For
AllianceBernstein0315,690 00Against
T. Rowe Price299,3650 00For
DIKER MANAGEMENT LLC279,6740 00For
HighTower Advisors, LLC257,7000 00For
Rhumbline215,2910 00For

Institutional-manager reports, all 110 managers: 184,595,511 for, 1,041,348 against, 1,917 abstained. Showing the 25 largest; see all in the interactive database.

5. 3. Ratification of Appointment of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 322,915,281AGAINST: 3,650,720
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025.

STANDARD BIOTOOLS INC.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Public Accounting Firm”): 322,915,281 for, 3,650,720 against — passed, per its Form 8-K filed June 20, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 was approved by the following vote:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 40 asset managers below reported 52,287,181 for.

FOR
FOR: 52,287,181
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm f” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,914,8130 00For
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce2,240,5030 00For
Neuberger Berman1,088,2720 00For
TIAA748,2940 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust245,8230 00For
Lincoln Financial218,8000 00For
Global X177,9030 00For
AIG/SunAmerica154,5260 00For
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock108,1740 00For
Voya86,4970 00For
ProShares59,0110 00For
SEI49,6000 00For
Victory Capital42,6220 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

Largest STANDARD BIOTOOLS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 379,822,268 shares outstanding at the time of that meeting.

Fund voting reports: top STANDARD BIOTOOLS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 4.43%
2BlackRock 3.06%
3Fidelity 1.34%
4ARK ETF Trust 0.83%
5Equitable 0.77%
6Morgan Stanley 0.75%
7Charles Schwab 0.67%
8Royce 0.59%
9Neuberger Berman 0.29%
10TIAA 0.20%
Institutional-manager reports: top STANDARD BIOTOOLS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed…”, 2024-2025
#Asset manager % of shares outstanding
1Casdin Capital, LLC 20.03%
2VIKING GLOBAL INVESTORS LP 15.44%
3Morgan Stanley 2.60%
4BlackRock 1.68%
5Nikko Asset Management Co., Ltd. 1.63%
6GEODE CAPITAL MANAGEMENT, LLC 1.41%
7Neuberger Berman 0.98%
8State Street 0.77%
9MAK CAPITAL ONE LLC 0.75%
10Charles Schwab 0.67%

Reported STANDARD BIOTOOLS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

STANDARD BIOTOOLS INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Eli Casdin 24.71% 13D
VIKING GLOBAL INVESTORS LP 15.44% 13D
BlackRock 6.48% 13F
Vanguard Group 4.54% 13F
Morgan Stanley 2.82% 13F
Geode Capital 1.90% 13F
State Street 1.67% 13F
Millennium Management 1.34% 13F
Northern Trust 0.73% 13F
Charles Schwab 0.64% 13F

Percentages above are of 379,822,268 shares outstanding, as reported by STANDARD BIOTOOLS INC. on its Form 10-Q dated May 1, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from STANDARD BIOTOOLS INC.’s 10-Q dated May 1, 2025. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.

At STANDARD BIOTOOLS INC.'s shareholder meeting held June 18, 2025, in the 2024-2025 proxy season, 137 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 741 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers as disclosed… — STANDARD BIOTOOLS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: STANDARD BIOTOOLS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 20, 2025.

STANDARD BIOTOOLS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.